RHOC and cancer: Our overall hypothesis—that RhoC amplifies interferon signaling and thereby increases junction dysregulation, consequently promoting cancer cells’ motility and invasiveness—is borne out insofar as RhoC contributes to Type I interferon cellular response and also contributes to regulation of junction behavior.